News

"Streamlining the development of clinical trials through in-home patient visits” was the presentation given by dr. Cristina Florescu Moraid at the “8th edition of the STOP Cancer Personalized Translational Oncology”, talking about the importance of home visits for patients enrolled in clinical trials in nowadays. Decentralized clinical trials represent the new...

First in person Annual Metting of Camina Medical Country Coordinators took place in Bucharest on 18th of November in Bucharest. An excellent moment to meet each other and exchange experience of performing coordination for home care Camina Medical projects across Europe. Thank you to all participants from Romania, Croatia, Poland, Lithuania, Ukraine, Greece, Serbia and Bosnia, Turkey, Russia, Hunga...

Campania „Santa Claus is coming to you” a ajuns la cea de-a doua ediție anul acesta și s-a încheiat pe 23 decembrie. Moș Crăciun și-a trimis și anul acesta ajutoarele mesageri din partea Avantyo Institute of Clinical Research, Arensia Exploratory Medicine, Eurofins, ARPIM, Namzya și Camina Medical, Asociatia Change for Change si a doamnelor Stanca Popescu, Craciunes...

“Santa Claus is coming to you” is the name of Xmas campaign organized by Avantyo Institute of Clinical Research together with companies Camina Medical and Arensia Exploratory Medicine, started on 16th of December and completed on 22nd of With this charity campaign “SANTA CLAUS IS COMING TO YOU” 16 families and 30 children from several rural localities, i.e.Aprozi (Calara...

COVID-19 has forced a change in ongoing clinical trials and demanded the development of new ways to operationalize clinical trials moving forward. Many previously avant-garde practices in clinical trial design and execution—such as e-consent forms, remote monitoring, and single-system digitized trial documentation—have now become the gold standard for COVID-19-era studies. It is likely...

Due to pandemic covid 19, we all face now new situations which change substantially our way of doing our routine work: impossibility of the patients to visit the site for performing the study visit, delays in the shipments of medication to site, questions regarding the stability of the study medication, monitors unable to visit the site, inspectors who cannot perform their routine inspectionsa at ...